Long-term Follow-Up and Exploratory Analysis of Lenvatinib in Patients with Metastatic or Recurrent Thymic Carcinoma: Results from the Multicenter, Phase 2 REMORA Trial
LUNG CANCER(2024)
关键词
Efficacy,Lenvatinib mesylate,Phase 2 clinical study,Relative dose intensity,Thymic carcinoma
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要